SUVRETTA CAPITAL MANAGEMENT, LLC

Adviser information for SUVRETTA CAPITAL MANAGEMENT, LLC last updated from Form ADV on March 26th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Liability Company
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 24
Investment Advisory/Research 15
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 12 $4.5B
Non-Discretionary 0 $0
Total 12 $4.5B

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 12 $4.5B
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other 0 $0
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 67

Services

Advisory Services Portfolio management for pooled investment vehicles
Compensation % of AUMPerformance-based fees
Other Business Activities Commodity pool operator or commodity trading advisor

Identifiers

SEC RIA File Number 801-79962
SEC ERA File Number 801-79962
SEC CIK Numbers 1569064
SEC CRD Numbers 165153
Legal Entity Identifier 549300B4WZUAJTMV4E82

Principal Office

540 MADISON AVENUE
7TH FLOOR
NEW YORK
NY
United States
Monday - Friday, 8:30 - 5:30
Tel: 212-702-5200, Fax: 212-702-5201

Websites

Chief Compliance Officer

ANDREW NATHANSON
GENERAL COUNSEL
540 MADISON AVENUE
7TH FLOOR
NEW YORK
NY
United States
Tel: (212) 702-5205
Fax: (212) 702-5201
(Full email address available in API data)

Regulatory Contact

GLENN SHEPARD
CFO
540 MADISON AVENUE
7TH FLOOR
NEW YORK
NY
United States
Tel: (212) 702-5204
Fax: (212) 702-5201
(Full email address available in API data)

Industry Affiliates

AVERILL GP, LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
AVERILL MADISON GP, LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
AVERILL OPPORTUNITIES, LLC Sponsor, GP, manager of pooled investment vehicles
SUVRETTA GP, LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
AVERILL MADISON MASTER FUND, LTD. Hedge Fund $316.1M $1.0M 12
AVERILL MASTER FUND, LTD. Hedge Fund $2,891.3M $1.0M 279
AVERILL OPPORTUNITIES OFFSHORE FUND I, LP Venture Capital Fund $7.4M $1.0M 39
SUVRETTA MASTER FUND, LTD. Hedge Fund $1,262.0M $1.0M 412

Control Persons

Name Type Entity Title Since Ownership
SHEPARD, GLENN, MICHAEL Individual CHIEF FINANCIAL OFFICER 09/2011 < 5%
COWEN, AARON, LEONARD Individual CHIEF EXECUTIVE OFFICER 09/2011 < 5%
NATHANSON, ANDREW, JON Individual GENERAL COUNSEL & CHIEF COMPLIANCE OFFICER 03/2014 < 5%
SUVRETTA CAPITAL, LP Domestic Entity MEMBER 01/2017 > 75%
COWEN, AARON, LEONARD Individual SUVRETTA CAPITAL, LP LIMITED PARTNER 01/2017 > 75%
SUVRETTA CAPITAL GP, LLC Domestic Entity SUVRETTA CAPITAL, LP GENERAL PARTNER 01/2017
COWEN, AARON, LEONARD Individual SUVRETTA CAPITAL GP, LLC MANAGING MEMBER 01/2017 > 75%

No. Employees, Historic

4020020202021202220232024202530 on 3/26/202030 on 5/29/202030 on 10/27/202030 on 12/7/202031 on 3/29/202132 on 3/28/202232 on 2/9/202332 on 3/27/202332 on 3/28/202332 on 6/14/202332 on 6/14/202324 on 3/26/2024

RAUM, Historic

8B4B02020202120222023202420255825656937 on 3/26/20205825656937 on 5/29/20205825656937 on 10/27/20205825656937 on 12/7/20207853949144 on 3/29/20217098443146 on 3/28/20227098443146 on 2/9/20235162283155 on 3/27/20235162283155 on 3/28/20235162283155 on 6/14/20235162283155 on 6/14/20234490893812 on 3/26/2024

No. Clients, Historic

201002020202120222023202420257 on 3/26/20207 on 5/29/20207 on 10/27/20207 on 12/7/202010 on 3/29/202112 on 3/28/202212 on 2/9/202315 on 3/27/202315 on 3/28/202315 on 6/14/202315 on 6/14/202312 on 3/26/2024

Holdings

From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
89BIO INC COM 64M 8M
ABBOTT LABS COM 3M 34K
ABEONA THERAPEUTICS INC COM NEW 16M 4M
ADVANCED MICRO DEVICES INC COM 56M 346K
AGILENT TECHNOLOGIES INC COM 647K 5K
ALIGN TECHNOLOGY INC COM 266K 1K
ALNYLAM PHARMACEUTICALS INC COM 9M 38K
AMAZON COM INC COM 69M 356K
APOLLO GLOBAL MGMT INC COM 42M 354K
APPLE INC COM 77M 363K
ARCELLX INC COMMON STOCK 84M 2M
ARCUS BIOSCIENCES INC COM 15M 957K
ARCUTIS BIOTHERAPEUTICS INC COM 93M 10M
ARRIVENT BIOPHARMA INC COM 32M 2M
AT&T INC COM 42M 2M
AVANTOR INC COM 2M 72K
BAXTER INTL INC COM 267K 8K
BENITEC BIOPHARMA INC COM NEW 12M 2M
BIOHAVEN LTD COM 180M 5M
BOSTON SCIENTIFIC CORP COM 19M 252K
CENCORA INC COM 3M 12K
CHARLES RIV LABS INTL INC COM 209K 1K
CHIPOTLE MEXICAN GRILL INC COM 25M 399K
COCA COLA CO COM 36M 561K
CONTINEUM THERAPEUTICS INC CL A 36M 2M
CRH PLC ORD 32M 432K
CVS HEALTH CORP COM 1M 17K
DANAHER CORPORATION COM 4M 16K
DEXCOM INC COM 667K 6K
EDWARDS LIFESCIENCES CORP COM 1M 11K
ELANCO ANIMAL HEALTH INC COM 4M 254K
ELEVANCE HEALTH INC COM 50M 91K
ERASCA INC COM 32M 14M
EXACT SCIENCES CORP COM 4M 94K
EYEPOINT PHARMACEUTICALS INC COM NEW 45M 5M
FERGUSON PLC NEW SHS 28M 145K
FIVE BELOW INC COM 833K 8K
FULCRUM THERAPEUTICS INC COM 16M 3M
GALAPAGOS NV SPON ADR 1M 47K
GE AEROSPACE COM NEW 33M 205K
GE HEALTHCARE TECHNOLOGIES I COMMON STOCK 6M 75K
GILEAD SCIENCES INC COM 3M 51K
GOLDMAN SACHS GROUP INC COM 35M 78K
HCA HEALTHCARE INC COM 1M 3K
HUMANA INC COM 729K 2K
ILLUMINA INC COM 911K 9K
IMMATICS N.V SHS 11M 947K
INFLARX NV COM 10M 6M
INSMED INC COM PAR $.01 169M 3M
INTRA-CELLULAR THERAPIES INC COM 107M 2M
INTUITIVE SURGICAL INC COM NEW 2M 5K
IONIS PHARMACEUTICALS INC COM 515K 11K
IQVIA HLDGS INC COM 2M 7K
JOHNSON & JOHNSON COM 13M 90K
KALVISTA PHARMACEUTICALS INC COM 49M 4M
KENVUE INC COM 3M 172K
KEZAR LIFE SCIENCES INC COM 4M 7M
KURA ONCOLOGY INC COM 146M 7M
MARINUS PHARMACEUTICALS INC COM NEW 4M 4M
MCDONALDS CORP COM 28M 110K
MCKESSON CORP COM 1M 2K
MEDTRONIC PLC SHS 1M 17K
MEREO BIOPHARMA GROUP PLC SPON ADS 270K 75K
META PLATFORMS INC CL A 84M 167K
METTLER TOLEDO INTERNATIONAL COM 3M 2K
MICROSOFT CORP COM 46M 104K
MOLECULAR PARTNERS AG ADS 3M 400K
MONTE ROSA THERAPEUTICS INC COM 10M 3M
MORGAN STANLEY COM NEW 448K 5K
NATERA INC COM 1M 10K
ORACLE CORP COM 35M 245K
PEPGEN INC COM 24M 2M
PINTEREST INC CL A 18M 410K
PROKIDNEY CORP CLASS A ORD SHS 23M 9M
PROTAGONIST THERAPEUTICS INC COM 1M 31K
RESMED INC COM 457K 2K
REVANCE THERAPEUTICS INC COM 150K 58K
ROYALTY PHARMA PLC SHS CLASS A 49M 2M
SANOFI SPONSORED ADR 10M 211K
SPDR S&P 500 ETF TR TR UNIT 272M 500K
SPYRE THERAPEUTICS INC COM NEW 3M 107K
STERIS PLC SHS USD 336K 2K
STRYKER CORPORATION COM 1M 4K
SUTRO BIOPHARMA INC COM 23M 8M
SYSCO CORP COM 37M 521K
TAIWAN SEMICONDUCTOR MFG LTD SPONSORED ADS 61M 351K
TESLA INC COM 27M 135K
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS 4M 268K
THE CIGNA GROUP COM 2M 5K
THERMO FISHER SCIENTIFIC INC COM 4M 7K
TOURMALINE BIO INC COM 2M 125K
ULTRAGENYX PHARMACEUTICAL IN COM 85M 2M
UNITEDHEALTH GROUP INC COM 82M 161K
VERALTO CORP COM SHS 523K 5K
VERIZON COMMUNICATIONS INC COM 25M 610K
WATERS CORP COM 914K 3K
ZIMMER BIOMET HOLDINGS INC COM 354K 3K
ZURA BIO LTD CLASS A ORD SHS 17M 5M